Organization Overview
Alternative names
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
anastrozole (arimidex) (1 trial)
apalutamide (erleada) (1 trial)
atezolizumab (Tecentriq) (3 trials)
bacille calmette-guerin (1 trial)
bendamustine (treanda) (2 trials)
bevacizumab (avastin) (14 trials)
bicalutamide (casodex) (2 trials)
blinatumomab (blincyto) (2 trials)
bortezomib (velcade) (4 trials)
brentuximab vedotin (adcetris) (2 trials)
capecitabine (xeloda) (8 trials)
carboplatin (paraplatin) (24 trials)
carfilzomib (kyprolis) (1 trial)
cetuximab (erbitux) (3 trials)
cisplatin (platinol) (28 trials)
crizotinib (xalkori) (4 trials)
cyclophosphamide (cytoxan) (5 trials)
cytarabine (cytosar-u) (6 trials)
darolutamide (Nubeqa) (1 trial)
dasatinib (sprycel) (4 trials)
daunorubicin (cerubidine) (2 trials)
docetaxel (taxotere) (13 trials)
doxorubicin (Doxil) (8 trials)
durvalumab (imfinzi) (3 trials)
etoposide (vepesid) (8 trials)
exemestane (aromasin) (2 trials)
Filgrastim (neupogen) (1 trial)
fludarabine (fludara) (1 trial)
fluorouracil (efudex) (18 trials)
gemcitabine (gemzar) (12 trials)
goserelin (zoladex) (3 trials)
hyaluronidase (human recombinant) (Hylenex) (1 trial)
interferon alpha-2b (Intron-A) (3 trials)
ipilimumab (yervoy) (11 trials)
irinotecan (Camptosar) (2 trials)
lenalidomide (revlimid) (8 trials)
leuprolide (lupron) (2 trials)
levocarnitine (carnitor) (1 trial)
lysergic acid diethylamide (1 trial)
mercaptopurine (purinethol) (1 trial)
mitomycin (mutamycin) (3 trials)
nivolumab (opdivo) (16 trials)
obinutuzumab (gazyva) (1 trial)
osimertinib (tagrisso) (3 trials)
oxaliplatin (eloxatin) (8 trials)
pazopanib (votrient) (1 trial)
pegaspargase (oncaspar) (1 trial)
pembrolizumab (keytruda) (9 trials)
pemetrexed (alimta) (5 trials)
prednisone (meticorten) (6 trials)
rituximab (rituxan) (7 trials)
sargramostim (leukine) (2 trials)
sorafenib (nexavar) (4 trials)
tamoxifen (nolvadex) (1 trial)
thalidomide (Thalomid) (1 trial)
trametinib (mekinist) (7 trials)
trastuzumab (herceptin) (3 trials)
triptorelin (Trelstar) (1 trial)
venetoclax (venclexta) (4 trials)
vinblastine (velban) (3 trials)
abiraterone (zytiga) (1 trial)
acalabrutinib (calquence) (1 trial)
afatinib (gilotrif) (3 trials)
aflibercept (zaltrap) (1 trial)
alemtuzumab (campath) (1 trial)
azacitidine (vidaza) (2 trials)
binimetinib (mektovi) (4 trials)
capivasertib (Truqap) (1 trial)
copanlisib (aliqopa) (1 trial)
encorafenib (braftovi) (1 trial)
fludeoxyglucose f-18 (3 trials)
fluoroestradiol (Cerianna) (1 trial)
fulvestrant (faslodex) (1 trial)
immune globulin (human) (Gamastan) (1 trial)
infliximab (remicade) (1 trial)
larotrectinib (vitrakvi) (1 trial)
mitoxantrone (novantrone) (1 trial)
nicotine (nicorette) (1 trial)
nilotinib (tasigna) (3 trials)
olaparib (lynparza) (2 trials)
palbociclib (ibrance) (3 trials)
rilimogene gamvacirepvec (1 trial)
romidepsin (istodax) (1 trial)
selumetinib (Koselugo) (1 trial)
sirolimus (rapamune) (1 trial)
sodium fluoride (18F) (1 trial)
sotorasib (LUMAKRAS) (2 trials)
temozolomide (temodar) (2 trials)
temsirolimus (torisel) (2 trials)
topotecan (hycamtin) (1 trial)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 2)
Adenocarcinoma, Mucinous (Phase 3)
Adenocarcinoma of Lung (Phase 2)
Adenoma, Islet Cell (Phase 2)
Anemia (Phase 3)
Anus Neoplasms (Phase 3)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma in Situ (Phase 2)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Merkel Cell (Phase 3)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Signet Ring Cell (Phase 3)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 2)
Carcinoma, Verrucous (Phase 3)
Cholangiocarcinoma (Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 2)
Cystadenocarcinoma (Phase 3)
Endometrial Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 2)
Fatigue (Phase 3)
Gallbladder Neoplasms (Phase 3)
Gastrinoma (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Glioma (Phase 2)
Glucagonoma (Phase 2)
Hodgkin Disease (Phase 1)
Hypersensitivity (Phase 3)
Insulinoma (Phase 2)
Kidney Neoplasms (Phase 2)
Laryngeal Neoplasms (Phase 2)
Leukemia (Phase 3)
Leukemia, Erythroblastic, Acute (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia, Megakaryoblastic, Acute (Phase 2)
Leukemia, Monocytic, Acute (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 3)
Leukemia, Myelomonocytic, Juvenile (Phase 3)
Leukemia, Promyelocytic, Acute (Phase 2)
Lip Neoplasms (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 3)
Melanoma (Phase 3)
Mouth Neoplasms (Phase 3)
Multiple Myeloma (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Neoplasm Metastasis (Phase 2)
Neoplasm, Residual (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Second Primary (Phase 3)
Neuroendocrine Tumors (Phase 2)
Neurotoxicity Syndromes (Phase 2)
Oropharyngeal Neoplasms (Phase 3)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 3)
Papilloma (Phase 2)
Papillomavirus Infections (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Philadelphia Chromosome (Phase 3)
Pneumonia (Phase 2)
Preleukemia (Phase 3)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 2)
Salivary Gland Neoplasms (Phase 3)
Skin Neoplasms (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Smoldering Multiple Myeloma (Phase 3)
Somatostatinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 3)
Syndrome (Phase 3)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Ureteral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Neoplasms (Phase 2)
Virus Diseases (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)